// App-Quantinova.ai

800 : Predictors of Maternal Morbidity Among Participants Enrolled in the Sickle Cell Disease Implementation Consortium Registry

Researchers

Presenter

  • Rita V Masese

Principal Investigators

  • Dominique Bulgin

  • Liliana Preiss

  • Mitchell Knisely

  • Eleanor Stevenson

  • Jane S. Hankins

  • Marsha Treadwell

  • Allison A. King

  • Victor R. Gordeuk

  • Julie Kanter

  • Robert Gibson

  • Jeffrey A. Glassberg

  • Paula Tanabe

  • Nirmish Shah

Medical Centers

  • Fuqua School of Business, Duke University, Durham, NC

  • Duke University Fuqua School of Business, Durham, NC

  • RTI International, Durham, NC

  • Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

  • Childrens Hospital & Research Center, Oakland, Oakland, CA

  • UCSF Benioff Childrens Hospital Oakland, Oakland, CA

  • Program in Occupational Therapy, Washington University in St. Louis, School of Medicine, Clayton, MO

  • Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL

  • Director, Adult Sickle Cell Program, Comprehensive Sickle Cell Center,, Birmingham, AL

  • Medical College of Georgia Cancer Center, Augusta University, Augusta, GA.

  • Division of Hematology and Oncology, Department of Medicine and Department of Emergency Medicine, Mount Sinai Medical Center, New York, NY

  • Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

  • School of Nursing and School of Medicine, Duke University, Durham, NC

  • Duke University Health System, Durham, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Deep vein thrombosis

  • Acute chest syndrome

  • Sickle cell anemia

  • Venous thrombosis

  • Preeclampsia

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A